Lotus Pharmaceutical Co Ltd 1795

Morningstar Rating
NT$101.50 −10.00 (8.97%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

1795 is trading at a LOCK|MSp#L premium.
Price
NT$101.50
Fair Value
LOCK|&.^K?mYHN
Uncertainty
LOCK|G@&hp
1-Star Price
LOCK|#.tJnpjfZ
5-Star Price
LOCK|X.>lB^PsCG
Economic Moat
LOCK|w>S
Capital Allocation
—

Trading Information

Previous Close Price
NT$111.50
Day Range
NT$100.50–108.50
52-Week Range
NT$100.50–364.76
Bid/Ask
NT$101.00 / NT$101.50
Shares Outstanding
266.39M
Market Cap
NT$27.04B
Volume/Avg
4M / 1M

Key Statistics

Price/Earnings (Normalized)
13.15
Price/Sales
0.86
Dividend Yield (Trailing)
2.53%
Dividend Yield (Forward)
2.53%
Dividend Payment Schedule
Oct
Total Yield
2.53%

Company Profile

Lotus Pharmaceutical Co Ltd is engaged in the healthcare sector. Along with its subsidiaries, it is engaged in the research and development, manufacturing, and sales of generic and branded pharmaceutical products, as well as consulting services. Its product portfolio comprises biosimilars, generic medicines, branded medicines, and various therapies in its research and development pipeline. The Group offers a differentiated portfolio of pharmaceuticals spanning several therapeutic areas, including oncology and immunology, CNS, women's health, primary care and lifestyle, and nephrology, among others. Geographically, it generates maximum revenue from the United States, and the rest from Taiwan, South Korea, Singapore, and other countries.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Mid Value
Total Number of Employees
1,099

Valuation

Metric
1795
Price/Earnings (Normalized)
13.15
Price/Book Value
1.09
Price/Sales
0.86
Price/Cash Flow
5.24
Price/Earnings
1795

Financial Strength

Metric
1795
Quick Ratio
0.82
Current Ratio
1.33
Interest Coverage
1.66
Quick Ratio
1795

Profitability

Metric
1795
Return on Assets (Normalized)
2.63%
Return on Equity (Normalized)
10.43%
Return on Invested Capital (Normalized)
8.61%
Return on Assets
1795

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
LOCK|vQ^r<^%!LOCK|d#FW$70B
Teva Pharmaceutical Industries Ltd
TEVA
LOCK|#!ZPL%cLOCK|?&Y?$47B
Haleon PLC ADR
HLN
LOCK|#plN&xLOCK|tzs$40B
Zoetis Inc Class A
ZTS
LOCK|<KCBTM<LOCK|<T$32B
Viatris Inc
VTRS
LOCK|>?#?%SRLOCK|JmH$23B
Elanco Animal Health Inc
ELAN
LOCK|@hLOCK|!<J$13B
Dr Reddy's Laboratories Ltd ADR
RDY
LOCK|GrnYMNLOCK|!s$12B
Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
LOCK|n&m!>@GLOCK|L<z$3B
Prestige Consumer Healthcare Inc
PBH
LOCK|j!p&lD$LOCK|?rHZ$2B
Perrigo Co PLC
PRGO
LOCK|HnphcGLOCK|#>@$2B

Sponsor Center